Abstract
A fast gas chromatography (GC)-MS method has been developed and validated for the simultaneous screening of different classes of drugs of abuse in urine. Tetrahydrocannabinol metabolite, cocaine, opiates such as morphine, O-6-monoacetylmorphine (O-6-MAM), codeine, opioids such as buprenorphine, methadone, pentazocine, fentanyl and analogues and their main metabolites can be detected and quantified after a simple liquid–liquid extraction in alkaline conditions and derivatisation to obtain the corresponding trimethylsilyl derivatives. The chromatographic separation is performed in a total time of 6 min, using a short GC column (5% phenyl methyl silicone, 10-m length × 0.18-mm internal diameter). The Limits of Detection are satisfactory for forensic purposes for all the substances; the repeatability of concentrations (percent coefficients of variation) are always lower than 15% at high and low concentration levels, and accuracy, intended as % error on the true value, is always lower than 15% for all the analytes. The method can successfully be applied for screening analyses in many fields of forensic toxicology.
Similar content being viewed by others
References
Bush DM (2008) The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations. Forensic Sci Int 174:111–119
Lillsunde P, Haavanlammi K, Partinen R, Mukala K, Lamberg M (2008) Finnish guidelines for workplace drug testing. Forensic Sci Int 174:99–102
Fraser AD, Zamecnik J (2002) Substance abuse monitoring by the Correctional Service of Canada. Ther Drug Monit 24:187–191
Rohrig TP, Moore C (2003) The determination of morphine in urine and oral fluid following ingestion of poppy seeds. J Anal Toxicol 27:449–452
Verstraete AG, Pierce A (2001) Workplace drug testing in Europe. Forensic Sci Int 121:2–6
European Workplace Drug Testing Society (2002) European Laboratory Guidelines for Legally Defensible Workplace Drug Testing. Available at: http://www.ewdts.org/guidelines/EWDTSGuidelines.pdf. Accessed 15 June 2010.
U.S. Substance Abuse and Mental Health Services Administration (2004) Mandatory Guidelines for Federal Workplace Drug Testing Program. Available at: http://www.workplace.samhsa.gov. Accessed 15 June 2010
Marquet P, Delpla PA, Kerguelen S, Bremond J, Facy F, Garnier M, Guery B, Lhermitte M, Mathé D, Pelissier AL, Renaudeau C, Vest P, Seguela JP (1998) Prevalence of drugs of abuse in urine of drivers involved in road accidents in France: a collaborative study. J Forensic Sci 43:806–811
Walsh JM, de Gier JJ, Christopherson AS, Verstraete AG (2004) Drugs and driving. Traffic Inj Prev 5:241–253
Jönsson AK, Holmgren P, Druid H, Ahlner J (2007) Cause of death and drug use pattern in deceased drug addicts in Sweden, 2002–2003. Forensic Sci Int 169:101–107
Lehrmann E, Afanador ZR, Deep-Soboslay A, Gallegos G, Darwin WD, Lowe RH, Barnes AJ, Huestis MA, Cadet JL, Herman MM, Hyde TM, Kleinman JE, Freed WJ (2008) Postmortem diagnosis and toxicological validation of illicit substance use. Addict Biol 13:105–112
World Anti-Doping Agency, Montreal (Canada) (2010) The World Anti-Doping Code. The 2010 Prohibited List International Standard. Available at: http://www.wada-ama.org. Accessed 15 June 2010.
López P, Bermejo AM, Tabernero MJ, Cabarcos P, Alvarez I, Fernández P (2009) Cocaine and opiates use in pregnancy: detection of drugs in neonatal meconium and urine. J Ana Toxicol 33:351–355
Ferrara SD, Tedeschi L, Frison G, Brusini G, Castagna F, Bernardelli B, Soregaroli D (1994) Drugs-of-abuse testing in urine: statistical approach and experimental comparison of immunochemical and chromatographic techniques. J Anal Toxicol 18:278–291
Garcia-Jimenez S, Heredia-Lezama K, Bilbao-Marcos F, Fuentes-Lara G, Monroy-Noyola A, Deciga-Campos M (2008) Screening for marijuana and cocaine abuse by immunoanalysis and gas chromatography. Ann NY Acad Sci 1139:422–425
von Mach M, Weber C, Meyer MR, Weilemann LS, Maurer HH, Peters FT (2007) Comparison of urinary on-site immunoassay screening and gas chromatography–mass spectrometry results of 111 patients with suspected poisoning presenting at an emergency department. Ther Drug Monit 29:27–39
Kyle PB, Spencer JL, Purser CM, Eddleman KC, Hume AS (2003) Suspected pediatric ingestions: effectiveness of immunoassay screens vs. gas chromatography/mass spectroscopy in the detection of drugs and chemicals. J Toxicol Clin Toxicol 41:919–925
World Anti-Doping Agency (2010) WADA Technical Document-TD2010IDCR. Available at: http://www.wada-ama.org. Accessed 15 September 2010.
Langman LJ, Bjergum MW, Williamson CL, Crow FW (2009) Sensitive method for detection of cocaine and associated analytes by liquid chromatography-tandem mass spectrometry in urine. J Anal Toxicol 33:447–455
Eichhorst JC, Etter ML, Rousseaux N, Lehotay DC (2009) Drugs of abuse testing by tandem mass spectrometry: a rapid, simple method to replace immunoassays. Clin Biochem 42:1531–1542
De Giovanni N, Strano-Rossi S (1994) Simultaneous detection of cocaine and heroin metabolites in urine by solid phase extraction and GC/MS. J Chromatogr B 658:69–73
Strano Rossi S, Molaioni F, Botrè F (2005) Application of solid-phase microextraction to antidoping analysis: determination of stimulants, narcotics, and other classes of substances excreted free in urine. J Anal Toxicol 29:217–222
Strano Rossi S, Molaioni F, Rossi F, Botrè F (2005) Rapid screening of drugs of abuse and their metabolites by gas chromatography/mass spectrometry: application to urinalysis. Rapid Comm Mass Spectrom 19:1529–1535
Gallardo E, Barroso M, Queiroz JA (2009) LC-MS: a powerful tool in workplace drug testing. Drug Test Anal 1:109–115
Rittner M, Pragst F, Bork W, Neumann J (2001) Screening method for seventy psychoactive drugs or drug metabolites in serum based on high-performance liquid chromatography–electrospray ionization mass spectrometry. J Anal Toxicol 25:115–124
Adamowicz P, Kała M (2010) Simultaneous screening for and determination of 128 date-rape drugs in urine by gas chromatography–electron ionization-mass spectrometry. Forensic Sci Int 198:39–45
van Thuyne W, Van Eenoo P, Delbeke FT (2008) Implementation of gas chromatography combined with simultaneously selected ion monitoring and full scan mass spectrometry in doping analysis. J Chrom A 1210:193–202
Thevis M, Schänzer W (2007) Current role of LC–MS(/MS) in doping control. Anal Bioanal Chem 388:1351–1358
WADA Technical Document-TD2010MRPL (2010). Available at: http://www.wada-ama.org. Accessed 15 September 2010.
Mazzarino M, Orengia M, Botrè F (2007) Application of fast gas chromatography/mass spectrometry for the rapid screening of synthetic anabolic steroids and other drugs in anti-doping analysis. Rapid Commun Mass Spectrom 21:4117–4124
Morra V, Davit P, Capra P, Vincenti M, Di Stilo A, Botrè F (2006) Fast gas chromatographic/mass spectrometric determination of diuretics and masking agents in human urine: Development and validation of a productive screening protocol for antidoping analysis. J Chromatogr A 1135:219–229
Húsková R, Matisová E, Hrouzková S, Svorc L (2009) Analysis of pesticide residues by fast gas chromatography in combination with negative chemical ionization mass spectrometry. J Chromatogr A 1216:6326–6334
Strano Rossi S, de la Torre X, Botrè F (2010) A fast GC-MS method for the determination of stimulants and narcotics in urine. Rapid Commun Mass Spectrom 24:1475–1480
Peters FT, Drummer OH, Musshoff F (2007) Validation of new methods. Forensic Sci Int 165:216–224
World Anti-Doping Agency (2009) International Standard for Laboratories. Available at: http://www.wada-ama.org. Accessed 15 September 2010.
U.S. Department of Health and Human Services Food and Drug Administration (2001) Bioanalytical methods validation. Available at: http://www.fda.gov/downloads/drugs. Accessed 17 November 2010
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Strano-Rossi, S., Bermejo, A.M., de la Torre, X. et al. Fast GC-MS method for the simultaneous screening of THC-COOH, cocaine, opiates and analogues including buprenorphine and fentanyl, and their metabolites in urine. Anal Bioanal Chem 399, 1623–1630 (2011). https://doi.org/10.1007/s00216-010-4471-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-010-4471-4